Thursday, November 06, 2014
This week, Kalamazoo, Michigan-based Stryker Corporation agreed to make payments to thousands of individuals injured by its Rejuvenate and ABG II hip implant devices that may reach $1.4 billion or more. The devices, manufactured by Stryker subsidiary Howmedica Osteonics Corp. and marketed under the names Rejuvenate and ABG II, were recalled in 2012 due to high failure rates related to tissue damage caused by corrosion and fretting of the devices metal components.
The settlement calls for base awards of $300,000 for each failed hip device, and enhanced awards for certain complications suffered during surgical removal and replacement. Only persons who have had the Rejuvenate or ABG II device removed and replaced or those too ill to undergo revision surgery are entitled to compensation under the settlement agreement.
Sommers Schwartz attorney Rob Sickels, himself a double hip implant recipient, is successfully representing injured patients against Stryker and continues to investigate potential claims.
To learn more, please visit our Video Library to watch a series of short videos discussing the problems associated with the Stryker Rejuvenate and ABG II products, the pain and injury resulting from their allegedly defective design, and the action that patients implanted with the devices should take to pursue their rights. You can also see additional coverage on our Stryker Defective Hip Implant page and our blog.